Shares of Tactile Systems Tech TCMD were flat in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share were down 140.00% year over year to ($0.12), which beat the estimate of ($0.15).
Revenue of $42,772,000 declined by 2.07% from the same period last year, which beat the estimate of $41,730,000.
Looking Ahead
The upcoming fiscal year's revenue expected to be between $215,300,000 and $224,500,000.
Conference Call Details
Date: May 03, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/bweakt6k
Technicals
52-week high: $64.53
Company's 52-week low was at $30.31
Price action over last quarter: Up 9.46%
Company Overview
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.